How should access to antiretroviral treatment be measured?
作者信息
Johnson Leigh F, Boulle Andrew
机构信息
Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Anzio Road, Observatory, 7925, Cape Town, South Africa.
出版信息
Bull World Health Organ. 2011 Feb 1;89(2):157-60. doi: 10.2471/BLT.10.080911.
Abstract
摘要
相似文献
1
How should access to antiretroviral treatment be measured?应如何衡量抗逆转录病毒治疗的可及性？
Bull World Health Organ. 2011 Feb 1;89(2):157-60. doi: 10.2471/BLT.10.080911.
2
Access to essential medications for HIV/AIDS in South Africa.南非艾滋病毒/艾滋病基本药物的获取情况。
S Afr Med J. 2001 May;91(5):384-7.
3
The ethics of expanding access to cheaper, less effective treatments.扩大获得更便宜但效果较差治疗方法的可及性的伦理问题。
Lancet. 2016 Aug 27;388(10047):932-4. doi: 10.1016/S0140-6736(15)01025-9. Epub 2016 Apr 20.
4
UN political declaration on HIV and AIDS: where to begin?联合国关于艾滋病毒和艾滋病问题的政治宣言：从何说起？
Lancet. 2016 Aug 20;388(10046):743-4. doi: 10.1016/S0140-6736(16)31336-8.
5
Learning and doing: operational research and access to HIV treatment in Africa.学习与实践：非洲的运筹学与艾滋病治疗获取情况
AIDS. 2010 Jan;24 Suppl 1:S1-4. doi: 10.1097/01.aids.0000366077.37827.0a.
6
Universal access to antiretroviral therapy: when, not if.普遍获得抗逆转录病毒疗法：何时实现，而非能否实现。
Clin Infect Dis. 2006 Jan 15;42(2):260-1. doi: 10.1086/499062. Epub 2005 Dec 12.
7
The Accelerating Access Initiative: experience with a multinational workplace programme in Africa.加速准入倡议：在非洲实施跨国工作场所方案的经验。
Bull World Health Organ. 2009 Oct;87(10):794-8. doi: 10.2471/blt.08.052027.
8
9
Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa.南非凯萨蒂沙的初级保健抗逆转录病毒治疗方案的 7 年经验。
AIDS. 2010 Feb 20;24(4):563-72. doi: 10.1097/QAD.0b013e328333bfb7.
10
UN report urges action towards universal HIV treatment access.联合国报告敦促采取行动，以实现普遍获得艾滋病毒治疗的目标。
Lancet Infect Dis. 2008 Jul;8(7):411. doi: 10.1016/s1473-3099(08)70141-5.
引用本文的文献
1
Progress towards the 2020 targets for HIV diagnosis and antiretroviral treatment in South Africa.南非在实现2020年艾滋病毒诊断和抗逆转录病毒治疗目标方面取得的进展。
South Afr J HIV Med. 2017 Jul 27;18(1):694. doi: 10.4102/sajhivmed.v18i1.694. eCollection 2017.
2
In Women's Eyes: Key Barriers to Women's Access to HIV Treatment and a Rights-Based Approach to their Sustained Well-Being.在女性眼中：女性获得艾滋病毒治疗的关键障碍以及基于权利的促进其持续福祉的方法。
Health Hum Rights. 2017 Dec;19(2):155-168.
3
Getting to 90-90-90 in paediatric HIV: What is needed?实现儿科艾滋病治疗的90-90-90目标：需要什么？
J Int AIDS Soc. 2015 Dec 2;18(7Suppl 6):20770. doi: 10.7448/IAS.18.7.20770. eCollection 2015.
4
HIV Treatment in Resource-Limited Environments: Treatment Coverage and Insights.资源有限环境下的艾滋病病毒治疗：治疗覆盖率与见解
Value Health. 2015 Dec;18(8):1113-9. doi: 10.1016/j.jval.2015.10.003. Epub 2015 Nov 12.
5
Targeting 90-90-90--don't leave children and adolescents behind.以“90-90-90”目标为导向——不要抛下儿童和青少年。
J Int AIDS Soc. 2015 Dec 2;18(Suppl 6):20745. doi: 10.7448/IAS.18.7.20745. eCollection 2015.
6
New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon.抗逆转录病毒治疗开始延迟的新指标：喀麦隆的估计数。
Bull World Health Organ. 2015 Aug 1;93(8):521-8. doi: 10.2471/BLT.14.147892. Epub 2015 Jun 1.
7
Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries.在低收入、中等收入和高收入国家开始接受抗逆转录病毒治疗的儿童中的免疫缺陷。
J Acquir Immune Defic Syndr. 2015 Jan 1;68(1):62-72. doi: 10.1097/QAI.0000000000000380.
8
Barriers and facilitators to linkage to ART in primary care: a qualitative study of patients and providers in Blantyre, Malawi.在初级保健中进行抗逆转录病毒治疗（ART）的衔接的障碍和促进因素：来自马拉维布兰太尔的患者和提供者的定性研究。
J Int AIDS Soc. 2012 Dec 31;15(2):18020. doi: 10.7448/IAS.15.2.18020.
9
Access to, and uptake of, antiretroviral therapy in a developing country with high HIV prevalence: a population-based cohort study in rural Uganda, 2004-2008.在一个 HIV 高发的发展中国家，获得和接受抗逆转录病毒治疗的情况：2004-2008 年乌干达农村一项基于人群的队列研究。
Trop Med Int Health. 2012 Aug;17(8):e49-57. doi: 10.1111/j.1365-3156.2012.02942.x.
本文引用的文献
1
Estimation of adult antiretroviral treatment coverage in South Africa.南非成人抗逆转录病毒治疗覆盖率的评估。
S Afr Med J. 2009 Sep;99(9):661-7.
2
Estimation of antiretroviral therapy coverage: methodology and trends.抗逆转录病毒疗法覆盖率的估计：方法学和趋势。
Curr Opin HIV AIDS. 2010 Jan;5(1):97-102. doi: 10.1097/COH.0b013e328333b892.
3
4
Use of immunological markers and continuous-time Markov models to estimate progression of HIV infection in homosexual men.使用免疫标记物和连续时间马尔可夫模型估计男同性恋者中HIV感染的进展情况。
AIDS. 1996 Jun;10(6):649-56. doi: 10.1097/00002030-199606000-00011.
5
The dynamics of CD4+ T-lymphocyte decline in HIV-infected individuals: a Markov modeling approach.HIV感染个体中CD4 + T淋巴细胞减少的动态变化：一种马尔可夫建模方法。
J Acquir Immune Defic Syndr (1988). 1991;4(11):1141-7.
Zotero 插件